Article
Dual role of glycosylation in resistance to CD4-binding site broadly neutralizing antibodies.
Journal of virology - 19 May 2026
Murphy Teresa, Kelly Meagan, Shimagaki Kai S, DeStefanis Thomas, Galeotos Gabriel, Lee Myungjin, Wei Qing, Novak Jan, Bar Katharine J, Barton John P, Lynch Rebecca M
Abstract excerpt
Broadly neutralizing antibodies (bNAbs) provide a useful tool for HIV cure strategies because of their ability to target conserved regions on the envelope (Env) protein in the context of both virions and infected cells. One of the best-studied bNAbs is the CD4 binding site (CD4bs) antibody VRC01 and others in its class. A major obstacle to effective cure strategies with bNAbs is viral immune escape. A deeper...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
